Cargando…
The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
A wide variety of oligomeric structures are formed during the aggregation of proteins associated with neurodegenerative diseases. Such soluble oligomers are believed to be key toxic species in the related disorders; therefore, identification of the structural determinants of toxicity is of upmost im...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879557/ https://www.ncbi.nlm.nih.gov/pubmed/35209093 http://dx.doi.org/10.3390/molecules27041293 |
_version_ | 1784658919978696704 |
---|---|
author | Xu, Catherine K. Castellana-Cruz, Marta Chen, Serene W. Du, Zhen Meisl, Georg Levin, Aviad Mannini, Benedetta Itzhaki, Laura S. Knowles, Tuomas P. J. Dobson, Christopher M. Cremades, Nunilo Kumita, Janet R. |
author_facet | Xu, Catherine K. Castellana-Cruz, Marta Chen, Serene W. Du, Zhen Meisl, Georg Levin, Aviad Mannini, Benedetta Itzhaki, Laura S. Knowles, Tuomas P. J. Dobson, Christopher M. Cremades, Nunilo Kumita, Janet R. |
author_sort | Xu, Catherine K. |
collection | PubMed |
description | A wide variety of oligomeric structures are formed during the aggregation of proteins associated with neurodegenerative diseases. Such soluble oligomers are believed to be key toxic species in the related disorders; therefore, identification of the structural determinants of toxicity is of upmost importance. Here, we analysed toxic oligomers of α-synuclein and its pathological variants in order to identify structural features that could be related to toxicity and found a novel structural polymorphism within G51D oligomers. These G51D oligomers can adopt a variety of β-sheet-rich structures with differing degrees of α-helical content, and the helical structural content of these oligomers correlates with the level of induced cellular dysfunction in SH-SY5Y cells. This structure–function relationship observed in α-synuclein oligomers thus presents the α-helical structure as another potential structural determinant that may be linked with cellular toxicity in amyloid-related proteins. |
format | Online Article Text |
id | pubmed-8879557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88795572022-02-26 The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity Xu, Catherine K. Castellana-Cruz, Marta Chen, Serene W. Du, Zhen Meisl, Georg Levin, Aviad Mannini, Benedetta Itzhaki, Laura S. Knowles, Tuomas P. J. Dobson, Christopher M. Cremades, Nunilo Kumita, Janet R. Molecules Article A wide variety of oligomeric structures are formed during the aggregation of proteins associated with neurodegenerative diseases. Such soluble oligomers are believed to be key toxic species in the related disorders; therefore, identification of the structural determinants of toxicity is of upmost importance. Here, we analysed toxic oligomers of α-synuclein and its pathological variants in order to identify structural features that could be related to toxicity and found a novel structural polymorphism within G51D oligomers. These G51D oligomers can adopt a variety of β-sheet-rich structures with differing degrees of α-helical content, and the helical structural content of these oligomers correlates with the level of induced cellular dysfunction in SH-SY5Y cells. This structure–function relationship observed in α-synuclein oligomers thus presents the α-helical structure as another potential structural determinant that may be linked with cellular toxicity in amyloid-related proteins. MDPI 2022-02-15 /pmc/articles/PMC8879557/ /pubmed/35209093 http://dx.doi.org/10.3390/molecules27041293 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Xu, Catherine K. Castellana-Cruz, Marta Chen, Serene W. Du, Zhen Meisl, Georg Levin, Aviad Mannini, Benedetta Itzhaki, Laura S. Knowles, Tuomas P. J. Dobson, Christopher M. Cremades, Nunilo Kumita, Janet R. The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity |
title | The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity |
title_full | The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity |
title_fullStr | The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity |
title_full_unstemmed | The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity |
title_short | The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity |
title_sort | pathological g51d mutation in alpha-synuclein oligomers confers distinct structural attributes and cellular toxicity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879557/ https://www.ncbi.nlm.nih.gov/pubmed/35209093 http://dx.doi.org/10.3390/molecules27041293 |
work_keys_str_mv | AT xucatherinek thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT castellanacruzmarta thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT chenserenew thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT duzhen thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT meislgeorg thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT levinaviad thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT manninibenedetta thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT itzhakilauras thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT knowlestuomaspj thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT dobsonchristopherm thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT cremadesnunilo thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT kumitajanetr thepathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT xucatherinek pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT castellanacruzmarta pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT chenserenew pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT duzhen pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT meislgeorg pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT levinaviad pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT manninibenedetta pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT itzhakilauras pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT knowlestuomaspj pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT dobsonchristopherm pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT cremadesnunilo pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity AT kumitajanetr pathologicalg51dmutationinalphasynucleinoligomersconfersdistinctstructuralattributesandcellulartoxicity |